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Abstract
Enzyme costs play a major role in the choice of metabolic routes, both in evolution and bioengi-
neering. Given desired fluxes, necessary enzyme levels can be estimated based on known rate laws and
on a principle of minimal enzyme cost. With logarithmic metabolite levels as free variables, enzyme
cost functions and constraints in optimality and sampling problems can be handled easily. The set
of feasible metabolite profiles forms a polytope in log-concentration space, whose points represent all
possible steady states of a kinetic model. We show that enzyme cost is a convex function on this
polytope. This makes enzyme cost minimization – finding optimal enzyme profiles and corresponding
metabolite profiles that realize a desired flux at a minimal cost – a convex optimization problem.
1 Introduction
The metabolic fluxes in cells are driven by enzymes, which come at a cost. Translating a given flux
profile into the necessary enzyme profile, and computing the corresponding enzyme cost, is not a trivial
task. In kinetic models, a reaction rates v = E · r(c) is a product of enzyme level E and an enzyme-
specific rate given by the rate law r(c). If metabolite levels were known, the enzyme demand could be
directly computed; the specific enzyme demand E/v = 1/r(c) is simply obtained by inverting the rate
law. However, since metabolite levels are not fixed, the fluxes in a network can be realized by many
possible enzyme profiles, each with a corresponding metabolite profile. To select a plausible solution, we
employ an optimality principle: we define an enzyme cost function (for instance, total enzyme mass) and
choose among all possible enzyme profiles the one with the lowest cost. As a constraint, the corresponding
metabolite profile must respect physiological ranges and energetic constraints implied by flux directions.
The enzyme demand in a reaction, at a given desired flux, depends on thermodynamic and kinetic factors.
To see what each factor contributes, we split the formula for enzyme demands into a product of terms, each
with a simple interpretation. The reaction rate depends on enzyme level, forward catalytic constant k+cat
(i.e., the maximal possible forward rate per mM of enzyme), driving force (which determines the relative
backward flux), and kinetic effects (such as substrate saturation or allosteric regulation) that modify the
forward flux (see Figure 1).
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Figure 1: The catalytic rate of enzymes is decreased by different physical factors. Under ideal conditions, an
enzyme molecule catalyses its reaction at a maximal rate, given by the enzyme’s forward catalytic constant
(top). The rate is reduced by microscopic reverse fluxes (center) and insufficient availability of substrate
(incomplete saturation, leading to waiting times between conversion events). As the catalytic rate of the
enzyme decreases (left), realizing a desired metabolic flux requires increasingly more enzyme (right).
2 Enzymatic rate laws
Reactions of the form A ⇌ B can be described by the reversible Michaelis-Menten kinetics. A generalized
form for reactions with multiple substrates (concentrations si) and products (concentrations pj) reads
v = E
k+cat
∏
i(
si
KM
i
)m
S
i − k−cat
∏
i(
pi
KM
i
)m
P
i
D(s1, s2, .., p1, p2, ..)
. (1)
The molecularities mSi and m
P
i represent the (positive) stoichiometric coefficients, but they may be scaled
by a reaction-specific factor which effectively acts like a Hill coefficient. Using a stoichiometric coefficient
nil and a molecularity m
S
li = 2|nil| is equivalent to using a Hill coefficient of 2 in the rate law. For reasons
of thermodynamic consistency, reaction rates must vanish in chemical equilibrium states; to ensure this,
equilibrium constants and rate constants must satisfy the Haldane relationship [1]
Keq =
∏
i(s
eq
i )
mSi∏
i(p
eq
i )
mP
i
=
k+cat
∏
i(K
M
i )
mPi
k−cat
∏
i(K
M
i )
mS
i
, (2)
where si and pj denote to substrate and product levels, respectively. Since the equilibrium constants depend
on the Gibbs energies of formation as Keq = e
−∆rG
◦′/RT , they must satisfy Wegscheider conditions [2]:
the vector of equilibrium constants satisfies lnKeq = N
tot⊤
µ
◦′, with the stoichiometric matrix Ntot
for all metabolites and the vector µ◦′ of transformed Gibbs free energies of formation. Accordingly, the
equilibrium constants must satisfy a Wegscheider condition lnKeq ·k = 0 for any thermodynamic cycle k,
i.e., any nullspace vector of Ntot
⊤
. The denominator D in Eq. (1) depends on the enzyme mechanism. In
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general, it is a polynomial
D(c) = 1 +
∑
k
Mlk
∏
i
cmliki (3)
of the metabolite concentrations with positive coefficients Mlk and exponents mlik. For examples of such
denominators, see appendix A. In the underlying enzyme mechanism, each sum term (index k) represents
a binding state of the enzyme. The exponents mlik indicate the numbers of reactant molecules bound
in one binding state and the prefactors encode the binding energies. The sum term 1 represents the
unbound enzyme. The highest-order substrate term reads
∏
i(si/K
M
i )
mSi and the highest-order product
term reads
∏
i(pi/K
M
i )
mPi . In addition, the denominator may contain additive or multiplicative terms
for allosteric activation and inhibition. The exponents mlik are usually positive integer numbers. With
allosteric regulation, however, there can also be denominator terms of the form KS/s.
3 Separable rate laws and enzyme cost
Following [3], we consider general reversible rate laws and factorize them into
v = ε · kcat · ηth · ηkin · ηreg, (4)
where kcat = k+cat is the forward catalytic constant. For an example of such a factorization, see appendix
B. The energetic efficiency
ηth = 1−
Γ
Keq
= 1− e−Θ (5)
depends on the mass-action ratio Γ (e.g., Γ = p/s for unimolecular reactions) and on the equilibrium
constant Keq, or briefly on the driving force Θ = −∆rG/RT . Note that our driving forces are defined
via molecularities, not via the stoichiometric coefficients; to allow for a consistent equilibrium state, all
reactants within a reaction must show the same Hill coefficient [4]. The relationship Γ/Keq = e
−Θ links
concentrations to driving forces and holds for ideal chemical mixtures with constant activity coefficients.
The kinetic efficiency ηkin depends on the rate law and can be derived from the rate law’s denominator.
For a general reversible rate law, the kinetic efficiency would read
ηkin =
∏
i(si/K
M
i )
mSi
D(s1, s2, .., p1, p2, ..)
(6)
where the substrate-dependent numerator
∏
i(si/K
M
i )
mSi stems from the positive numerator term in the
rate law and the denominator D is given by the rate law denominator. A factorized formula (4), called
separable rate law [3], exists for reactions of arbitrary stoichiometry (for examples, see SI A). The fac-
torization is always possible even for general rate laws, because rate law numerators must have the form
k+cat
∏
i (si/K
M
li)
mSli − k−cat
∏
i(pi/K
M
li)
mPli for reasons of thermodynamic consistency.
The terms in the rate law (4) depend on metabolite levels in different ways. The first terms, ε·k+cat, represent
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(a) Reversible Michaelis-Menten kinetics (factorized, with driving force θ = −∆rG/RT )
v = ε · k+cat · [1− e
−θ]︸ ︷︷ ︸
ηth
·
s/KS
1 + s/KS + p/KP︸ ︷︷ ︸
ηkin
·
1
1 + x/KI︸ ︷︷ ︸
ηreg
Rate = Enzyme level · Forward catalytic constant · Energetic efficiency · Kinetic efficiency
(b) Enzyme cost function (factorized form)
y = h · ε = h · v ·
1
k+cat
·
1
[1− e−θ]︸ ︷︷ ︸
1/ηth
·
1 + s/KS + p/KP
s/KS︸ ︷︷ ︸
1/ηkin
· [1 + x/KI]︸ ︷︷ ︸
1/ηreg
Figure 2: Separable rate law and enzyme cost function. (a) Reversible rate laws can be factorized [3].
The example shows a reaction S ⇌ P with reversible Michaelis-Menten kinetics Eq. (??) and a factor for
non-competitive allosteric inhibition (inhibitor concentration x). (b) The enzyme cost y (enzyme level ε,
multiplied by the specific enzyme cost h) contains the terms from the rate law in inverse form. By omitting
some terms (or replacing them by constant numbers), one obtains simplified enzyme cost functions.
the maximal velocity (the rate at full substrate-saturation, no backward flux, full allosteric activation), while
the following efficiency terms describe how this velocity is reduced in reality: the factor ηth describes a
reduction due to backward fluxes, and the factors ηkin and ηth describe a further reduction due to incomplete
substrate saturation and allosteric regulation. While k+cat is an enzyme-specific constant (yet, dependent
on conditions such as pH, ionic strength, or molecular crowding in cells; unit 1/s), the efficiency terms
are concentration-dependent, unitless, and can vary between 0 and 1. The thermodynamic efficiency ηth
depends on the driving force (and thus, indirectly, on metabolite levels) and the equilibrium constant is
required for its calculation. The kinetic efficiency ηkin depends directly on metabolite levels and contains
the KM values as parameters. Allosteric regulation can be captured by ηkin (as additive or multiplicative
terms in the denominator), but non-competitive allosteric regulation can also be described by a separate
term ηreg. If rate law, flux, and metabolite levels are known, a reaction’s enzyme demand follows from
Eq. (4) as
εl(v, c) = vl ·
1
kcatl
·
1
ηthl (Θ(c))
·
1
ηkinl (c)
·
1
ηregl (c)
. (7)
By weighting the enzyme demand with an enzyme-specific cost hl, we obtain the cost function
yl(vl, c) = hl ·
1
kcatl︸ ︷︷ ︸
Υ
(1)
l
·
1
ηthl (c)︸ ︷︷ ︸
[1−e−Θl(c)]−1
·
1
ηkinl (c)
·
1
ηreg(c)
· vl = Υl(c) vl (8)
Dividing Eq. (8) by vl, we obtain the specific flux cost Υl = yl/vl = hl/rl. Eq. (8) shows which factors
shape enzyme cost, and how. The first two terms yield the minimal cost Υ
(1)
l = hl/k
cat
l (the cost per
flux under ideal conditions); the following terms further increase this value. To keep enzyme cost low,
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Figure 3: Enzyme demand in a metabolic pathway. (a) Pathway with reversible Michaelis-Menten kinetics
(equilibrium constants and KM values are set to 1). The external metabolite levels x and y are fixed, while
internal levels a and b can vary. Plots (b)-(d) show the enzyme demand for reactions 1, 2, and 3 (enzyme
levels needed to sustain the desired unit flux). Regions of infeasible metabolite profiles are shown in grey. At
the edges of the admissible region (where chemical equilibrium would obtain), the thermodynamic driving
force goes to zero; this must be compensated by a high enzyme level. The enzyme demand in reaction 1
(shown in (b)), for instance, increases with the level of A (x-axis) and goes to infinity as the mass-action
ratio a/x reaches the equilibrium constant (where the driving force vanishes). (e) Total enzyme demand
(sum of enzyme levels). The metabolite polytope – the intersection of feasible regions for all reactions – is
a triangle, and the enzyme demand is a cup-shaped function on this triangle. The minimum point marks
the optimal metabolite levels, from which optimal enzyme levels can be computed.
the kcat values, driving forces (i.e. imbalance in substrate and product levels), and substrate saturation
(i.e. high substrate concentrations) should be high. For a pathway with desired fluxes vl and known
log-concentrations xi = ln ci, the total cost reads
ypw(x) =
∑
l
yl(v, c) =
∑
l
hl εl(vl, c). (9)
Setting hl = 1, we obtain the total enzyme demand (as a concentration in mM), and setting hl = ml
(protein mass in Daltons), we obtain the mass concentration (in gram protein per cell dry weight) as a
special case.
4 The metabolite polytope represents the states of a kinetic model
A metabolic network (with given flux directions, equilibrium constants, and metabolite bounds) defines a
convex metabolite polytope P in the space of log-concentrations xi = ln ci (where ci is measured in units
of the standard concentration cσ = 1 mM). An example is shown in Figure 3. In general, the polytope arises
from two sorts of inequality constraints: (i) Upper and lower bounds xmini ≤ xi ≤ x
max
i for metabolite
levels yield a box-shaped metabolite polytope; some metabolite levels may also be constrained to a fixed
value. (ii) Reaction fluxes dissipate Gibbs energy (Θl ·vl > 0), so the driving forces must be positive in the
direction of the flux. The resulting constraints 0 < Θl =
1
RT∆rG
′◦
l +
∑
i ln ci further restrict the metabolite
5
polytope; they define E-faces of the polytope (representing an equilibrium condition), where enzyme costs
rise steeply. The metabolite polytope is a convex polytope in log-concentration space, which contains all
feasible metabolite profiles. It is bounded by two types of faces: faces that represent an equilibrium in one
of the reactions (“E-face”), where enzyme cost goes to infinity; and faces stemming from physiological
metabolite bounds (“P-face”). Minimum points of the enzyme cost function can be inside the polytope or
on P-faces. The polytope’s precise shape depends on the Enzyme Cost Function (ECF) score chosen (i.e,
on the simplifications applied) and on rate laws, rate constants, and specific enzyme costs hl in the model.
The metabolite polytope plays a central role in enzyme cost minimization: For a given model and flux
profile v, the points of the polytope parametrize the set of all possible steady states (ε, c,v). Feasible
metabolite profiles (represented by polytope points) can be uniquely mapped to enzyme profiles, while the
mapping from enzyme to metabolite profiles need not be unique. The entirety of metabolic states (or
all steady states) of a kinetic model can be parametrized as follows: we consider the (non-convex) flux
polytope and construct, for each point, the metabolite polytope. The construction yields all steady states
(characterized by concentrations, fluxes, enzyme levels) exactly once (while the same enzyme profile may
appear several times). Using this fact, we can parametrize all metabolites states of a kinetic model in a
simple and systematic way (for details, see appendix C). However, a restriction to stable steady states is
not easily possible.
5 Enzyme cost is a convex function on the metabolite polytope
The enzyme cost functions (8) and (9) are differentiable convex functions on the metabolite polytope (proof
in SI D). Convexity means that an interpolated metabolite vector, on a line between two log-concentration
vectors xa and xb, has a cost that is higher than (or at most equal to) the interpolated cost:
∀λ ∈ [0, 1] : ypw(λxa + (1− λ)xb) ≤ λ ypw(xa) + (1− λ) ypw(xb). (10)
To show that the ECF scores are convex, we consider the most general rate laws with denominator (3) and
rewrite it in the form
v = ε · k+cat · η
th · ηkin, (11)
implying the enzyme cost function
y =
∑
l
yl =
∑
l
hl vl
kcatl
·
1
ηthl
·
1
ηkinl
(12)
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for a pathway. The efficiency terms are given by
ηth = 1− e−Θ = 1− exp
(
1
RT
∆rG
◦′ +
∑
i
ni ln ci
)
ηkin =
∏
i
(
si
KMi
)−mSi ∑
k
Mk
∏
j
cmiki

−1 =

∑
k
αk
∏
j
caiki

−1 (13)
with coefficients αk ∈ R+ and aik ∈ R. The regulation efficiency η
reg can be neglected because it can
always be covered by the term ηkin. The cost function (12) with efficiency terms (13) is convex on the
metabolite polytope. The function stays convex if the investment function H(ε) is not linear, but convex.
Importantly, even though all ECF scores are convex, they may not be strictly convex (in which case there
would be a < sign, instead of ≤, in Eq. (10)). For instance, simplified ECF scores can be constant in the
metabolite polytope. Non-strict convexity can arise when the mapping from enzyme to metabolite profiles
is not unique. However, it is possible to enforce a unique optimum by adding a convex regularization term
yreg, e.g., a quadratic function favoring metabolite levels in the center of the typical concentration range.
Such terms can be justified by biological side objectives: for instance, keeping metabolite levels away from
their upper or lower bounds in advance will later allow cells to vary them more flexibly. We can also
consider a variant of ECM with an additional metabolite-dependent objective z. Instead of minimizing the
enzyme cost alone, we then minimize the difference yeffpw(x) = ypw(x)−z
met(x). For instance, an objective
zmet(ln c) =
∑
i γi (ln ci − ln cˆi)
2 would represent a preference for metabolite levels close to “ideal” levels
cˆi, with cost weights γi. If z
met(x) is strictly concave, −z can be used as a regularization term yreg. The
resulting effective cost yeffpw will be strictly convex even if the term z is very small.
The convexity proof suggests that enzyme levels can be predicted with relatively little effort. Enzyme cost
minimization uses a metabolic network, a given flux profile v, and possibly kinetic rate laws (with their
thermodynamic or kinetic constants), and specific enzyme costs. The flux profile may be stationary (like
flux profiles determined by FBA) or non-stationary (like experimentally measured fluxes, simply inserted
into a model). In any case, it must be free of thermodynamically unfeasible cycles, and must agree with the
assumed equilibrium constants and external metabolite levels. If the given flux directions are infeasible, the
metabolite polytope will be an empty set. To find an optimal state, we choose an ECF score and minimize
the total enzyme cost within the polytope. Optimal metabolite profiles, enzyme profiles, and enzyme costs
are obtained by solving the Enzyme Cost Minimization (ECM) problem
yopt(v) = minx∈P ypw(x)
x
opt(v) = argmin
x∈P ypw(x)
ε
opt(v) = ε(v, copt(v)) (14)
for log-concentration vectors x = ln c. The total cost ypw(x) (see Eq. (9)) is a sum of enzyme costs (8)
or simplified ECF scores. If there is no unique optimum for x (because the cost function is constant along
some subspace, and therefore not structly convex), a unique solution can be enforced by adding a convex
regularization term yreg(x) to ypw. Since the optimal enzyme levels depend on external metabolite levels,
they must be recalculated after changes in external conditions. If non-enzymatic reactions (typically with
7
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Figure 4: Two ways of framing enzyme allocation as an optimality problem. (a) Benefit-cost optimization.
Each enzyme profile determines a metabolic state (with state variable vectors v and c and a metabolic
objective z(v, c)) and an investment h(ε1, ε2, ..). To predict an optimal enzyme profile, we maximize the
difference z−h. (b) In ECM, a predefined flux profile is realized by an enzyme profile (and a corresponding
metabolite profile) with a minimal investment; a concentration objective can be considered in addition.
Using the metabolite concentrations as free variables makes the problem relatively easy to solve.
mass-action rate laws) are included in the optimality problem, they contribute to the energetic constraints,
but not to the enzyme cost function.
6 Discussion
In summary, we saw that logarithmic metabolite levels are suitable variables for screening, sampling, and
optimizion of metabolic states. Due to the mapping from metabolite profiles to enzyme profiles, all feasible
enzyme profiles can be reached, where bounds on driving forces can be formulated as linear constraints.
Moreover, using the metabolite log-concentrations as free variables does not only provide a good search
space, but also facilitates the optimization problem: under general and reasonable assumptions, the ECF
scores are convex functions on the metabolite polytope. Convexity holds for a wide range of rate laws,
including rate laws with allosteric regulation. As a consequence, the optimization remains tractable for
various rate laws and larger metabolic networks. Strict convexity (required for an isolated optimum point)
can be enforced by adding small regularization terms yreg, possibly representing biological side objectives.
Optimal enzyme allocation in kinetic models can be framed in two main ways. One the one hand, enzyme
levels can be treated as control variables which determine the metabolic state, and thus the fluxes (see,
e.g., [5, 6]). The aim is to find the enzyme profile that leads to an optimal state (where enzyme cost can
come into play as a constraint or as a penalty functions). On the other hand (as in [7, 8] and here), one
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can predefine the fluxes and search for enzyme levels that realize them in an optimal way (here, minimal
cost is used as the optimality criterion). Both approaches address similar problems and lead to equivalent
solutions. For instance, if we first maximize a flux at a fixed total enzyme level, as in [6], and then use
this flux as a constraint in ECM (with identical specific costs for all enzymes), we recover the metabolite
and enzyme profile from the initial calculation. In fact, both optimality problems can be derived from a
common general optimality problem by constraining the fluxes or the total enzyme cost. The approaches
frame the same problem, but in different ways. Using fluxes as a scaffold for model construction has
several advantages. First, it makes the optimality problem convex. Second, we can precisely specify the
flux state to be modelled. Third, the flux cost functions yopt(v) can be used in flux analysis. Thus, ECM
enables more realistic variants of FBA; the cost function may contain additional side objectives scoring the
metabolite levels. If flux profiles are compared at a given flux benefit, it is only the cost scores that count
in the optimization, so cost and benefit can be measured in different units. In benefit-cost approaches
as in Figure 4 (a), enzyme investment and metabolic objective are directly compared and show the same
physical units. In order to make them comparable, a relative weighting would have to be established, which
bears the problem of arbitrariness.
Our fundamental assumption – that enzyme levels are cost-optimized in every moment – is of course
debatable. Instead, proteins may be expressed to higher amounts to anticipate sudden challenges (exam-
ple: energy production in muscle cells). Preemptive protein expression can avoid costs for rearranging
the proteome and performance losses during adaptation; however, in ECM it would appear futile. Also
flexibility in metabolite concentrations can be important, and cells might trade it against enzyme economy.
Furthermore, enzyme and metabolite levels in cells are not only shaped by demands in a single pathway,
but also by other pathways outside the model in question. Finally, if proteins are used as an amino acid
storage, there will be little pressure to keep them at low concentrations. How can our method be useful
despite all this? First, an account of simple enzyme economy can be a basis for studying more complicated
optimality requirements afterwards. Second, despite all these points of critique, enzyme economy may be
the main requirement, e.g., during fast, nitrogen-limited growth. Third, we can study how deviations from
the optimal state affect enzyme cost, and thus fitness. Finally, ECM can be extended to include more
objectives and constraints into our pathway model, and thus to account for the surrounding cell. The
metabolites from our pathway may also be involved in other pathways outside the model. If these other
pathways demand higher or lower metabolite levels, we can implement this fact in ECM by constraints
(upper and lower concentration bounds) or by concentration-dependent side objectives zmet(c), which pe-
nalize unfavorable metabolite levels. Trade-offs between the pathway in focus and other pathways around
it can be handled in this way. Alternatively, we can assume that each metabolite level should be close
to the centre of its allowed range (which also provides flexibility, because it will not easily hit a bound).
Again, this can be captured by side objectives.
As a possible application, enzyme cost functions allow us to define non-linear flux costs for use in flux
balance analysis. ECM is based on a given flux profile. However, since it can be applied to any flux
profile, it defines a flux cost function yopt(v), which can be applied in flux prediction. FBA with minimal
fluxes (fmFBA) compares flux profiles at equal benefit (FBA objective) and minimizes their heuristic cost.
The flux cost functions used are linear (for a predefined choice of flux directions). Linearity simplifies
calculations, but is not very realistic: first, cost scores like the sum of fluxes do not account for kinetics
9
and regulation; second, the costs add linearly when flux distributions are linearly combined. Flux cost
functions obtained from ECM, and based on a kinetic model, are more realistic. In an mfFBA based on
such cost functions, one would predefine flux directions, flux bounds, and a flux benefit zˆv · v = bˆ, and
assume stationary fluxes; but instead of a linear flux cost, one would minimize the flux cost yopt(v). Flux
costs derived from ECM are concave functions on the flux polytope (with given flux directions). This implies
that the solutions of the new fmFBA problems will be elementary flux modes, which confirms findings from
other enzyme optimality approaches [9, 10]. In fact, the flux cost function yopt(v) can be expected to be
strictly concave (except for specific cases, e.g. models containing two identical reactions with identical rate
laws). If this is this case, elementary flux modes are the only solutions. As a consequence, splitting a flux
profile into elementary modes that run in different compartments or at different time points can be better,
but never worse than the original flux profile in terms of enzyme cost.
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∑
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Reaction directions are defined in such a way that fluxes are positive. To define log-concentrations, we use
the standard concentration cσ = 1mM (shown here, but omitted elsewhere for simplicity.)
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A Kinetic rate laws
By considering simple enzyme mechanisms with few binding states, we obtain general rate laws applicable
to all reaction stoichiometries. The rate law denominators to be used in Eq. (1) have simple structures
(containing only few of the possible sum terms, and with prefactors following from a few Michaelis-Menten
constants) [4]. If denominator terms are omitted, the rate will be overestimated, i.e., enzyme demand and
costs will be underestimated. First, there are rate laws with denominators
D(S) =
∏
i
(si/K
M
i )
mSi
D(SP) =
∏
i
(si/K
M
i )
mSi +
∏
j
(pj/K
M
j )
mPi (15)
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which lead to the energetics-based ECF2 scores. The big product terms are called principal substrate and
product terms. As before, si and pj denote substrate and product levels. The first formula assumes that
substrate levels are high and product levels are low; the second one assumes that substrate and product
levels are both high. Next, there are rate laws with denominators
D(1S) = 1 +
∏
i
(si/K
M
i )
mSi
D(1SP) = 1 +
∏
i
(si/K
M
i )
mSi +
∏
j
(pj/K
M
j )
mPi (16)
which lead to the saturation-based ECF3 scores. The denominators contain only three possible terms: the
term 1, the principal substrate term, and the principal product term. To justify these rate laws, we assume
a strongly cooperative binding between substrates and between products. The first formula assumes low
product concentrations; the second formula describes the direct-binding modular rate law [4]. The direct-
binding modular rate law is a generalized version of reversible MM kinetics. In the underlying enzyme
mechanism, the enzyme exists in three states: fully bound with substrates, fully bound with products, or
empty. If enzymes are allosterically regulated, the rate law denominators contain additive or multiplicative
terms for regulation [4]. Additive terms can arise from competitive regulation. Multiplicative terms (for
non-competitive regulation) can be split from the denominator and treated as prefactors in the rate law.
Typical choices are x
x+kA
X
for non-competitive activation and
kIX
x+kI
X
for non-competitive inhibition, with
rate constants kA and kI and regulator concentration x [4]. Accordingly, allosteric effects can either be
listed by a separate efficiency term in the factorized ECF formulae, or be included in the kinetic efficiency.
For instance, the kinetic efficiency term for MM-kinetics with non-competitive inhibition can be split into
ηkin =
s/KS
(1 + xKI )(1 +
s
KS
+ pKP )
=
1
1 + sKS +
p
KP
1
(1 + x/KI)
= ηkin∗ ηreg. (17)
B Factorization of rate laws
To demonstrate how rate law are factorized, we consider the common modular rate (CM) law [11, 4], a
generalized form of reversible MM kinetics with the denominator
D(CM) =
∏
i
(1 + si/K
M
i )
mSi +
∏
j
(1 + pj/K
M
j )
mPi − 1. (18)
In the assumed enzyme mechanism, substrate molecules bind independently, product molecules bind inde-
pendently, and substrate and product binding exclude each other. For a bimolecular reaction A + B ⇋
P +Q, the rate law
v = ε
k+cat
[A][B]
KA KB
− k−cat
[P ][Q]
KP KQ
(1 + [A]KA )(1 +
[B]
KB
) + (1 + [P ]KP ((1 +
[Q]
KQ
)− 1
(19)
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can be rewritten as
= ε k+cat
[A][B]
KA KB
−
k−cat
k+cat
[P ][Q]
KP KQ
(1 + [A]KA +
[B]
KB
+ [A][B]KAB +
[P ]
KP
+ [Q]KQ +
[P ][Q]
KPQ
)
= ε k+cat
1− e−Θ
KA KB
[A][B] (1 +
[A]
KA
+ [B]KB +
[A][B]
KAB
+ [P ]KP +
[Q]
KQ
+ [P ][Q]KPQ )
= ε k+cat [1− e
−Θ]ηkin (20)
where we defined the kinetic efficiency
ηkin =
1
KA KB
[A][B] (1 +
[A]
KA
+ [B]KB +
[A][B]
KAB
+ [P ]KP +
[Q]
KQ
+ [P ][Q]KPQ )
(21)
and used the Haldane relationshipKeq =
k+cat
k−cat
KP KQ
KA KB
and the identity e−Θ = [P ][Q][A][B]/Keq. In the calculation,
we first separated the k+cat value from the rest of the fraction, and then hid the negative flux term in the
energetic efficiency term ηth.
C Parametrizing all states of a kinetic model
In a kinetic model with given rate laws and external metabolite concentrations, an enzyme profile (ε1, ..ε2, ..)
lead to a steady state with metabolite levels c and fluxes v. The following proposition shows how the set
S of such steady states σ = (ε, cv) can be easily parametrized.
Proposition: Consider a kinetic model with rate laws vl = εl rl(c), thermodynamically consistent rate
constants (satisfying Wegscheider conditions and Haldane relationships), a feasible positive flux profile v,
and bounds on metabolite levels. Any feasible metabolite profile ln c ∈ P can be realized by some positive
enzyme profile ε; given the metabolite levels, the enzyme levels are uniquely determined and given by
εl(ln c) = vl/rl(c), which is a differentiable function on the metabolite polytope.
Proof: If a metabolite profile c is feasible for the given flux profile v, the specific rates rl(c) obtained from
reveresible rate laws (see Eq. (1) in appendix) have the same signs as vl, so εl = vl/rl(c) is positive on
the entire metabolite polytope. Since rl(c) is differentiable and does not change its sign on the metabolite
polytope, εl(ln c) is differentiable on the metabolite polytope.
According to our proposition, any thermodynamically feasible metabolite profile can be realized by some
steady state of the kinetic model (with an appropriate choice of enzyme levels), so the set S of metabolic
states with a given flux profile v can be characterized by points of the metabolite polytope. In particular,
the set of kinetically realizable metabolite profiles depends on the equilibrium constants, but not on enzyme-
specific rate constants.
With simplified rate laws, the same enzyme profile may be realizable by different metabolite profiles. (i) If
a metabolite appears in a model but has no impact on any reaction, its concentration can be freely varied,
independently of the enzyme levels. (ii) With simplified cost scores in which all efficiencies ηth, ηkin, and
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ηreg are taken to be constant, enzyme levels do not depend on metabolite levels. (iii) With simplified
scores in which ηkin and ηreg are taken to be constant, enzyme costs depend on metabolite levels only
through the thermodynamic forces. Notably, the vector x = ln c can be varied along directions in the
nullspace of Ntot
⊤
without affecting the driving forces or enzyme cost. Thus, the enzyme cost scores have
an invariant subspace on the metabolite polytope (namely the nullspace of Ntot
⊤
). Under what conditions
more complicated enzyme cost scores (without regularisation terms) have unique optima remains an open
question.
Finally, to parametrize all steady states of a kinetic model, we can follow a two-step procedure in which
we enumerate all possible flux distributions and, for each of them, all possible enzyme and metabo-
lite profiles. The thermodynamically feasible flux distributions v form a set V , given by V = {v|∃x :
sign(v) = sign(−∆rG
′(x)}, where x stands for log-concentration profiles. The reaction Gibbs ener-
gies ∆rG
′
l = ∆rG
′◦
l + RT
∑
i nil ln ci depend on the internal and external metabolite levels and on
the equilibrium constants chosen. According to thermodynamic condition, whether a flux distributions
is feasible or infeasible depends solely on its sign pattern. By imposing upper and lower bounds and
the stationarity condition, we can further limit this set and obtain the set of feasible, stationary fluxes
Vstat = {v|vmin ≤ v ≤ vmax ∧ Nv = 0 ∧ ∃x : sign(v) = sign(−∆rG(x)}. V
stat is a (generally non-
convex) polytope in flux spaces. Each flux distribution v in this set defines a set of possible states Sv, one
can then set S = {(ε, c,v)|v ∈ V ∧ (ε, c) ∈ Sv}.
D Convexity proof for enzyme cost functions
To prove the convexity of general enzyme cost functions, on the metabolite polytope and at given desired
fluxes, we first show the convexity of some simple functions appearing in the formula.
D.1 General lemmata
Lemma 1 The function f(y) = − ln(1− ey) is convex in the range y < 0.
Proof D.1 The second derivative
d
dy2
f(y) =
ey
(1− ey)2
is positive for y < 0.
Lemma 2 The function f(x) = ln
∑n
k=1 e
xk is convex.
Proof D.2
∇2f(x) =
Dg(c)(1⊤c)− c c⊤
(1⊤c)2
(where ci = e
xi)
∀u : u⊤∇2f(x)u =
(
∑
i ciu
2
i )(
∑
i ci)− (
∑
i uici)
2
(
∑
i ci)
2
≥ 0
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since (
∑
i ui ci)
2 ≤ (
∑
i ci u
2
i )(
∑
i ci) from the Cauchy-Schwarz inequality. Therefore, the Hessian∇
2f(x)
is positive semi-definite, which proves that f(x) is convex.
Lemma 3 For any number ν ∈ R+ and vector n ∈ R
m, the function − ln(1 − ν en·x) is convex over
{x ∈ Rm | ν en·x < 1}.
Proof D.3 This function is a composition of f = − ln(1−ey) from Lemma 1 with the affine transformation
y = n · x+ ln ν, an operation which preserves convexity.
Lemma 4 For any matrix A ∈ Rn×m and vectors b ∈ Rn+, the following function is convex over x ∈ R
m:
ln
(
n∑
k=1
eak·x+bk
)
(22)
where ai is the ith row of A.
Proof D.4 This function is a composition of f = ln
∑n
i=1 e
xi from Lemma 2 with the affine transformation
xi = ai · x+ bi, an operation which preserves convexity.
D.2 The convexity of enzyme cost functions
Lemma 5 Assume that all enzyme-catalysed reactions in a model behave according to rate laws of the
type
v = ε · k+cat · η
th · ηkin, (23)
with ηth and ηkin given by Eq. (13), with coefficients αk ∈ R+ and aik ∈ R. Assume that the enzyme
cost function for enzymatic reaction l reads
yl =
hl vl
εl
=
hl vl
kcatl
·
1
ηthl
·
1
ηkinl
. (24)
Then the total enzyme cost y =
∑
l yl, as a function of logarithmic metabolite concentrations (x = ln c),
is convex.
Proof D.5 To simplify the efficiency terms, we can use the abbreviations xi ≡ ln ci, ν ≡ exp(∆rG
◦′/RT ),
and bk = lnαk:
ηth = 1− ν e−n·x
ηkin =
(
n∑
k=1
eak·x+bk
)−1
. (25)
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If we look at the natural logarithm of yl,
ln yl = ln
(
hl vl
kcatl
)
− ln ηthl − ln η
kin
l , (26)
we see that each of the three terms in the sum is convex in x. The first term is constant with respect to the
metabolite concentrations and therefore trivially convex. The energetic term, − ln ηth = − ln(1−ν e−n·x),
is convex according to Lemma 3. The kinetic term, − ln ηkin = ln
(∑n
k=1 e
ak·x+bk
)
, is convex according
to Lemma 4. We conclude that yl is convex too, since it is a composition of a convex function (e
x) with
another convex function (ln yl). Finally, the total enzyme cost (y) is convex since it is a sum of convex
functions:
y =
∑
l
yl(x). (27)
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